4//SEC Filing
Arcadia Biosciences, Inc. 4
Accession 0001209191-16-095497
$RKDACIK 0001469443operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:33 PM ET
Size
7.0 KB
Accession
0001209191-16-095497
Insider Transaction Report
Form 4
Rey Eric J.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2016-02-01$2.93/sh−3,000$8,794→ 140,380 total - Sale
Common Stock
2016-02-03$2.78/sh−200$556→ 140,180 total
Footnotes (3)
- [F1]The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective December 14, 2015.
- [F2]This transaction was executed in multiple trades at prices ranging from $2.80 to $3.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Includes 750 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on February 1, 2016.
Documents
Issuer
Arcadia Biosciences, Inc.
CIK 0001469443
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001469443
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:33 PM ET
- Size
- 7.0 KB